This article comprises a summary of scientific sessions on β-thalassaemia that took place on 2nd–4th February 2017, as part of the European Hematology Association Scientific Working Group meeting: Anaemias: Diagnosis and Treatment in the Omics Era, in Barcelona, Spain
Social Impact and Quality of Life of Patients with β-Thalassaemia: A Systematic Review
22 Mins